CARIS LIFE SCIENCES, INC. Other Noncash Income (Expense)
CARIS LIFE SCIENCES, INC. (CAI) reported Other Noncash Income (Expense) of $27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $241.00K.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$214.00K.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$428.00K.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for the quarter ending 2025-09-30 was $443.00K.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for fiscal 2025 was -$1.22M.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for fiscal 2024 was -$4.03M, a 403.31% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. other noncash income (expense) for fiscal 2023 was $1.33M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $27.00K 10-Q · filed 2026-08-05 | -$401.00K derived: sum of 3 quarters · filed 2026-08-05 | $42.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$214.00K 10-Q · filed 2026-05-08 | -$642.00K derived: sum of 2 quarters · filed 2026-05-08 | -$199.00K derived: sum of 3 quarters · filed 2026-05-08 | -$974.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $15.00K derived: sum of 2 quarters · filed 2026-03-03 | -$760.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.22M 10-K · filed 2026-03-03 |
| 2025-09-30 | $443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$332.00K derived: sum of 2 quarters · filed 2026-08-05 | -$788.00K 10-Q · filed 2025-11-05 | -$872.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.23M 10-Q · filed 2026-08-05 | -$1.31M derived: sum of 3 quarters · filed 2026-08-05 | -$3.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$456.00K 10-Q · filed 2026-05-08 | -$540.00K derived: sum of 2 quarters · filed 2026-05-08 | -$2.35M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.90M derived: sum of 2 quarters · filed 2026-03-03 | -$4.03M 10-K · filed 2026-03-03 | |
| 2024-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.95M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$2.13M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $1.33M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |